1-7 of 7
Monica Lopez-Guerra, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloproliferative/Myelodysplastic Neoplasms Presenting All Diagnostic Criteria of Chronic Myelomonocytic Leukemia but with Absolute Peripheral Blood Monocytosis 0.5-1× 10 9 /L Should be Classified As CMML

Sandra Castaño-Díez, Monica Lopez-Guerra, PhD, Daniel Esteban, Francesca Guijarro, MD, Alex Bataller Torralba, MD, Paola Charry, MD, Carlos Castillo, MD, Carlos Jiménez-Vicente, MD, Colomer Dolors, María Rozman, MD, Jordi Esteve, Marina Diaz-Beyá, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-142819
Published: 2020
Journal Articles

Validation of the European Leukemianet 2017 Prognostic Classification for Patients with De Novo Acute Myeloid Leukemia Treated with a Risk-Adapted Protocol (CETLAM 2012)

Alex Bataller, MD, Ana Garrido, MD, Francesca Guijarro, MD, Marina Diaz-Beyá, MD, Guadalupe Oñate, MD, Montserrat Hoyos, Montserrat Arnan, MD, Mar Tormo, MD, Susana Vives, MD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Rosa Coll, MD, David Gallardo, MD, Ferran Vall-Llovera, MD, Lourdes Escoda, MD, Antonia Sampol, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD, Joan Bargay, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD, Lurdes Zamora, PhD, Salut Brunet, MD, Josep F Nomdedeu, MD, Jorge Sierra, MD, Jordi Esteve
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-140670
Published: 2020
Journal Articles

Emergence of NPM1 Wild-Type Myeloid Neoplasms after Chemotherapy for Acute Leukemia with NPM1 Mutation: Proposed Mechanisms of Clonal Evolution

Sandra Castaño-Díez, Monica Lopez-Guerra, PhD, Francesca Guijarro, MD, Alex Bataller Torralba, MD, Daniel Esteban, Carlos Castillo, MD, Carlos Jiménez-Vicente, MD, Paola Charry, MD, Colomer Dolors, María Rozman, MD, Jordi Esteve, Marina Diaz-Beyá, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-142740
Published: 2020
Journal Articles

Triple Negative Myelofibrosis and Myelodysplastic Syndrome with Fibrosis: Clinico-Biological Characterization and Correlation with Gene Mutations

Juan Gonzalo Correa, MD, Alberto Alvarez-Larrán, MD PhD, Monica Lopez-Guerra, PhD, Juan Carlos Hernandez Boluda, MD PhD, Mar Tormo, MD PhD, María Rozman, MD PhD, Daniel Martínez, MD, Dolors Colomer, PhD, Jordi Esteve, MD PhD, Francisco Cervantes, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4299.
https://doi.org/10.1182/blood-2018-99-115888
Published: 2018
Journal Articles

Targeting IRAK4 Disrupts Inflammatory Pathways and Delays Tumor Development in Chronic Lymphocytic Leukemia

Neus Giménez Carabaza, B.Pharm, Rosich Laia, PhD, Schulz Ralph, MS, Higashi Morihiro, MD, Marta Aymerich, Neus Villamor, PhD, Julio Delgado, MD, Manel Juan, MD, Monica Lopez-Guerra, PhD, Elias Campo, Martina Seiffert, PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2650.
https://doi.org/10.1182/blood-2018-99-115999
Published: 2018
Journal Articles

Favorable Outcome in Patients with Acute Myeloblastic Leukemia (AML) with NPM1 Mutation Who Present an Inadequate Clearance or Relapse of Minimal/Measurable Residual Disease (MRD): Results of a Preemptive Intervention Policy (CETLAM-2012 Protocol)

Alex Bataller Torralba, MD, Marina Diaz-Beyá, MD, Ana Garrido, MD, Susana Vives, MD, Mar Tormo, MD PhD, Montserrat Arnan Sangerman, MD, Olga Salamero, MD, Antonia Sampol, MD PhD, Rosa Coll, MD, Monica Lopez-Guerra, PhD, Marta Pratcorona, MD PhD, Lurdes Zamora, PhD, Eva Villamón, PhD, Gael Roue, PhD, Adoración Blanco, PhD, Aina Oliver-Caldes, MD, Josep F Nomdedeu, MD, Dolors Colomer, PhD, Salut Brunet, MD PhD, Jorge Sierra, MD, Jordi Esteve, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1385.
https://doi.org/10.1182/blood-2018-99-110895
Published: 2018
Journal Articles

Notch1 Signaling in NOTCH1 -Mutated Mantle Cell Lymphoma Depends on DLL4 and Is a Potential Target for Specific Antibody Therapy

Elisabeth Höring, MD, Berta Colom Sanmarti, Silvia Xargay-Torrent, PhD, Walter E Aulitzky, MD, Heiko van der Kuip, PhD, Elias Campo, Mónica López-Guerra, PhD, Dolors Colomer, PhD
Journal: Blood
Blood (2016) 128 (22): 1846.
https://doi.org/10.1182/blood.V128.22.1846.1846
Published: 2016